For some people, nothing can top a morsel of luxuriously rich, premium chocolate. But until now, other than depending on their taste buds, chocolate connoisseurs had no way of knowing whether they were getting what they paid for. In ACS' ...
Tags: Premium Chocolate, Chocolate, Food
Google recently sent several of its employees to meet with staff from FDA’s medical device branch. Bloomberg speculates that the new product could be tied to biosensors. The employees in question hail from the company’s Google ...
Tags: Medical Device, Google
A new study seeks to determine how one parasitic species can give rise to two drastically different outcomes in its host: The human body louse (Pediculus humanus) can transmit dangerous bacterial infections to humans, while the human head ...
Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms. In a paper published by the ...
Tags: genetic diseases, RNA, nuclear magnetic resonance spectroscopy
Authorities in the Inner Mongolia autonomous region are considering building a successful business model for ecological industry on the vast prairies, but it's not a straightforward task. Wang Kaihao reports from Hohhot. It has been six ...
Tags: Green Grass
Women with aggressive breast cancer who receive combination targeted therapy with chemotherapy prior to surgery have a slightly improved chance of staying cancer-free, researchers say. However, the improvement was not statistically ...
Tags: aggressive breast cancer, targeted therapy with chemotherapy
A "misfire" is the way Eric Topol, MD, describes 23andMe's recent regulatory tussle with the FDA, which resulted in the Silicon Valley-based company halting sales for now of its health-related genetic test analysis. Speaking with MPMN ...
Tags: 23andme, FDA, regulatory tussle
Rosetta Genomics, a provider of microRNA-based molecular diagnostics, has obtained a conditional approval from the New York State Department of Health (NYSDOH) for its Rosetta Kidney Cancer Test for testing on patient samples from the ...
Tags: Rosetta Kidney Cancer, Medicine
HOUSTON — Mattress Firm has appointed industry veteran and philanthropist Roger Magowitz executive director of the Mattress Firm Foundation. He will oversee the day-to-day operations of the foundation, which raises awareness and funds ...
Tags: Mattress Firm, Roger Magowitz, Mattress Firm Foundation, appointment
Next-generation genetic sequencing, the idea of cheap and accessible testing, is one of the trendy areas in the medical device industry and a potential game-changer in the testing equipment sector. Just this week, GenapSys of Redwood ...
US-based Illumina has announced the introduction of its TruGenome undiagnosed disease test provided by Illumina Clinical Services Laboratory (ICSL). Using whole human genome sequencing, the TruGenome test helps clinicians in identifying ...
Tags: Illumina, Undiagnosed Disease Test
US-based BioNano Genomics has announced the launch of the IrysChip V2, a new, high-throughput chip for the Irys system that now supports human genome analysis. With a 15-fold increase in throughput, the new chip now makes possible the ...
Biopharmaceutical firm Berg and the Icahn School of Medicine at Mount Sinai have entered into a pharmaceutical and diagnostic R&D deal to leverage the power of multi-omic biology and data analytics. The deal is intended to secure new ...
US-based Illumina has launched its TruSight One Sequencing Panel, a broadest sequencing panel that targets 4,813 genes with known associated clinical phenotypes. Laboratories can use this panel to expand existing menus, streamline ...
Tags: Illumina, Sequencing Panel
Intel, increasingly customising server chips for customers, is now tuning chips for workloads in big data. Software is becoming an important building block in chip design, and customization will help applications gather, manage and ...